Annals of Oncology Conference

date

2022

related documents

1108P Outcomes when stage IV non-small cell lung cancer (NSCLC-4) patients (pts) harboring oncogenic drivers (OD) are treated initially without tyrosine kinase inhibitors (TKI) Proceedings (Faculty180)